Brian E. Schwartz, n/a

Intensity Therapeutics
Shelton, Connecticut, United States

Disclosure information not submitted.

Presentation(s):

• Paper 78 - A MULTICENTER, RANDOMIZED, PHASE 3 STUDY OF INTRATUMORAL INT230-6 (SHAO, VINBLASTINE, CISPLATIN) COMPARED TO STANDARD OF CARE THERAPY IN SELECTED METASTATIC SOFT TISSUE SARCOMAS: INVINCIBLE-3 TRIAL.

  Saturday, November 16, 2024
  9:00 AM – 10:00 AM PST